Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding

Mary-Carmel Kearney, Helen Quinn

Research output: Contribution to specialist publicationArticle

Abstract

Researchers at Queen’s University Belfast have developed a novel microarray patch to deliver antibiotics for the treatment of neonatal sepsis, a significant cause of childhood mortality that accounts for 26-36% of neonatal deaths globally. The potential of this microarray patch to offer an affordable, less-invasive and user-friendly treatment option was recently recognised by Saving Lives at Birth, a scheme which aims to identify and fund novel, scalable and sustainable solutions to improve infant and maternal health.
Original languageEnglish
Volume13
No.2
Specialist publicationInfant Journal
Publication statusPublished - 01 Mar 2017

Fingerprint Dive into the research topics of 'Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding'. Together they form a unique fingerprint.

Cite this